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Venous thromboembolism (VTE) is a common complication during 
and after hospitalisation for acute medical illness and surgery. 
Untreated proximal deep vein thrombosis (DVT) is associated with a 
30 - 50% rate of pulmonary embolism (PE), which is regarded as the 
most common cause of preventable death in hospitalised patients, 
contributing to 10% of all in-hospital deaths.[1-4] In addition to the 
acute risk of mortality, VTE is also associated with the long-term 
risk of post-thrombotic syndrome and post-thrombotic pulmonary 
hypertension. The multinational ENDORSE (Epidemiologic Inter-
national Day for the Evaluation of Patients at Risk for Venous 
Thromboembolism in the Acute Hospital Care Setting) study showed 
that more than half of hospitalised patients are at risk of VTE and 
that surgical patients have a higher risk (64%) than medical patients 
(41.5%).[1] In terms of local data, the second wave of the Gauteng 
Province-based TUNE-IN (The Use of VTE prophylaxis in relatioN 
to patiEnt risk profiling) study included 453 inpatients from multiple 
surgical specialties, a third of whom were from the state sector, and 
found that 92% were at risk of VTE.[5]
In 2007, the National Institute for Health and Care Excellence 
(NICE) recommended that all patients admitted to hospital should 
undergo a formal VTE risk assessment, and that appropriate 
prophylaxis should be prescribed.[6] In 2012, the American College 
of Chest Physicians (ACCP) published antithrombotic therapy and 
prevention of thrombosis guidelines, which uses the Caprini risk 
assessment model (RAM) to assess the degree of VTE risk.[7] 
SA guidelines were published in 2013, which closely mirror the 
previous ACCP guidelines.[4,8] Despite the unfavourable figures and 
formalised recommendations, thromboprophylaxis is found to be 
under-prescribed. Worldwide data suggest that >50% of hospitalised 
patients are at risk of DVT, with only half of these receiving an ACCP-
recommended method of prophylaxis.[7,9]
SA public sector data on VTE risk and adherence to prophylaxis 
prescription guidelines are lacking, especially from provinces such 
as the Eastern Cape, where there is a lack of resources and infra-
structure.[10,11] The objective of this study was therefore to evaluate 
the VTE risk and prescription of adequate prophylaxis to surgical 
patients at a tertiary government hospital in Eastern Cape Province.
Methods
A cross-sectional audit of general surgical inpatients was performed 
on two dates during July and August 2017. The two dates were 30 days 
apart to avoid overlap of patients with a prolonged admission. The 
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timing of the study and its objectives were at no stage discussed 
with treating surgeons or ward staff to avoid affecting prescription 
behaviour.
Inclusion criteria were adult patients admitted to general surgical 
wards in the Department of General Surgery, comprising elective and 
emergency admissions, the latter including trauma and burn patients. 
Those ˂18 years of age or those who were treated in the intensive 
care unit (ICU) were not included. Patients who refused consent to 
participate in the study were excluded. 
For each patient, individual risk factors for VTE were recorded 
and the overall VTE risk score was calculated using the Caprini 
RAM (Table 1), with the final VTE risk categorised as low, moderate, 
high and highest (Table 2). Medication charts were reviewed to 
assess for current thromboprophylaxis therapy and compared with 
therapy suggested by the Caprini RAM and ACCP guidelines.[2,7] 
Contraindications to thromboprophylaxis, as mentioned in the 
ENDORSE and AVAIL-ME (Assessment for VTE Management in 
Hospital – Middle East) studies, were also recorded.[1,9] A patient with 
a VTE score of ≥2 was considered ‘at risk’ and regarded as receiving 
correct therapy if the prophylactic treatment met the minimum 
therapy recommended for their risk category. Patients who did not 
receive the minimum therapy required for their risk category, or 
had clearly documented contraindications to chemoprophylaxis 
but nonetheless received it, were considered to be administered the 
incorrect therapy. 
Ethical approval
Ethical approval for this study was granted by the East London 
Hospital Complex (affiliated with Walter Sisulu University) ethics 
review board.
Results
Demographics
Of 181 eligible patients, 179 were included in the study – in 2 cases 
consent could not be obtained. Of those included, 56% were male 
and 44% female. The average age of patients was 45 (range 18 - 83) 
years. There were 59 elective surgical admissions and 120 emergency 
admissions. Emergency admissions comprised 80 acute surgical, 
23 trauma and 17 burn patients.
Risk assessment
With application of RAM, 77% of patients were at risk of DVT 
(Caprini score ≥2), with 81% of elective and 74% of emergency 
admissions being at risk. The most prevalent risk factors for VTE 
Table 1. Modified Caprini risk assessment model[4]
Each of the following risk 
factors represents 1 point
Each of the following 
risk factors represents 
2 points
Each of the following risk 
factors represents 
3 points
Each of the following 
risk factors represents 
5 points
For women only (1 point 
each)
Age 41 - 60 years
Minor surgery planned
History of prior major 
surgery (<1 mo)
Varicose veins
History of inflammatory 
bowel disease
Swollen legs (current)
Obese (BMI >25)
Acute myocardial infarction
Congestive heart failure
(<1 mo)
Sepsis (<1 mo)
Abnormal pulmonary 
function (COPD)
Medical patient (current bed 
rest)
Other risk factors (excluding 
diabetes)
Age 60 - 74 years
Major surgery (>45 min)
Arthroscopic surgery
Laparoscopic surgery 
(>45 min)
Previous and current 
malignancy
Morbid obesity (BMI 
>40 kg/m2)
Patient confined to bed 
(>72 h)
Immobilising plaster cast 
(>72 h)
Central venous access
Age ≥75 years
History of SVT, DVT/PE
Family history of DVT/PE
Congenital thrombophilia
Positive factor V Leiden
Positive prothrombin 
20210A
Elevated serum homo-
cysteine
Acquired thrombophilia
Positive lupus anti-
coagulant
Elevated anticardiolipin 
antibodies
Heparin-induced 
thrombocytopenia
Elective major lower-
extremity arthroplasty
Hip, pelvis or leg fracture 
(<1 mo)
Stroke (<1 mo)
Multiple trauma (<1 mo)
Acute spinal cord injury 
(paralysis) (<1 mo)
Oral contraception or HRT
Pregnancy or postpartum
Unexplained stillbirth,   
miscarriage (>3), SGA
HRT = hormone-replacement therapy; SVT = supraventricular tachycardia; DVT/PE = deep vein thrombosis/pulmonary embolism; SGA = small for gestational age; BMI = body mass index; 
COPD = chronic obstructive pulmonary disease.
Table 2. Caprini risk assessment model categories and recommended prophylaxis[2,8,12]
Risk factor 
score, total Incidence of DVT, % Risk level Prophylaxis regimen
0 - 1 <10 Low No specific measures, early ambulation
2 10 - 20 Moderate ES/GCS, IPC, LDUH or LMWH
3 - 4 20 - 40 High IPC, LDUH or LMWH
≥5 40 - 60
(1 - 5 mortality)
Highest Pharmacological: LDUH, LMWH, warfarin or F-Xa inhibitor alone 
or in combination with ES/GCS or IPC
DVT = deep vein thrombosis; ES/GCS = elastic stockings/graduated compression stockings; IPC = intermittent pneumatic compression; LDUH = low-dose unfractionated heparin; 
LMWH = low-molecular-weight heparin; F-Xa = factor Xa.
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were major surgery (34%), age 41 - 60 years (30%), age 61 - 74 years 
(20%) and sepsis during the previous month (27%). Other notable 
risk factors were minor surgery (16%), malignancy (9%), patient 
being bed bound for >72 hours (7%), and a history of major surgery 
within the previous month (6%).
Contraindications to chemoprophylaxis
Of the total number of patients included in the study, a contra-
indication to chemoprophylaxis was recorded in 53 (30%). The 
most common contraindications were: renal dysfunction (40%), 
peptic ulcer disease (34%), active bleeding (17%), liver dysfunction 
(17%), coagulopathy (6%) and recent cerebral haemorrhage (6%). Of 
these 53 patients, 34 (19% of total patients) were also at risk of VTE 
(Caprini score ≥2), necessitating mechanical prophylaxis. Despite a 
clear contraindication, 10 of the 34 patients received some form of 
chemoprophylaxis.
Therapy
Of the total number of at risk patients, 26% received the correct 
thromboprophylactic treatment according to their risk factor profile, 
while 21% of elective patients and 27% of emergency patients received 
the correct therapy. The number of patients in each risk group and 
the rate of correct prescription of prophylaxis are shown in Table 3.
Discussion
VTE is a common complication during and after hospitalisation 
and is considered the most common preventable cause of inhospital 
mortality worldwide. Despite its significance, there is a paucity of data 
to describe the VTE risk and prophylaxis prescription in SA surgical 
patients, especially in the public sector. This study therefore aimed 
to describe the VTE risk and prophylaxis prescription practices at a 
tertiary public hospital in the Eastern Cape. 
With application of the Caprini RAM, 77% of patients were 
found to be at risk of DVT. This figure is higher than the average 
of 64% in the ENDORSE study, but within the range of 44 - 80% for the 
32 partici pating nations.[1] In terms of prophylaxis prescription, 26% of 
patients in the current study were found to be receiving the correct 
thromboprophylaxis according to their risk factor profile. The rate 
of adequate VTE prophylaxis is therefore much lower than that in 
the ENDORSE study, where the overall correct rate of prophylaxis 
prescription in surgical patients was 59%.[1]
The low correct prophylaxis prescription rate may be owing to the 
initial assessment and management of patients in this hospital setting 
usually being done after hours by junior doctors (interns), who 
might not possess the experience to gauge VTE risk clinically or be 
confident to prescribe anticoagulation medication safely. Considering 
that emergency patient admissions formed a large portion of the 
sample (67%), of whom most would have been admitted after hours 
by intern doctors, this may be a significant factor. The high burden of 
acute surgical, trauma and burn cases in many secondary and tertiary 
hospitals in SA, indicates that reliance on junior doctors to manage 
patients after hours is unlikely to be unique to this hospital. Although 
after-hours admissions are reviewed during a post-intake consultant-
led ward round the next day, time spent with each patient is limited 
and thus the medication charts may not be fully reviewed for each 
patient during a busy and problem-focused round. For resource-
limited settings, such as the public sector in the Eastern Cape where 
many senior posts are unfilled, daily consultant-led ward rounds 
are often not feasible; hence, greater responsibility falls upon the 
shoulders of junior doctors, who may lack the experience to evaluate 
ongoing VTE risk once the patient is admitted. 
VTE risk for elective and emergency admissions was fairly similar 
– 81% and 74%, respectively. However, in terms of prophylaxis, 
the correct therapy was prescribed to only 21% of elective patients 
compared with 27% of emergency patients. Although VTE is a problem 
in all patients, it is an enormous problem in patients admitted for an 
elective procedure/work-up, where a favourable outcome is usually 
anticipated, especially when a catastrophic event such as fatal PE 
occurs. Although elective patients are admitted from the surgical 
outpatient department, where there is usually consultant supervision, 
the responsibility again primarily falls upon the interns to clerk and 
admit these patients, including their ward prescription charts. 
Another factor contributing to poor adherence to prophylaxis 
guidelines was the lack of availability of mechanical prophylaxis in the 
surgical wards at Frere Hospital. Therefore, a patient with a Caprini 
score of ≥2, who also had a clear contraindication to chemoprophylaxis, 
was automatically regarded as receiving the incorrect therapy. Given 
that 19% of all patients included in the study needed mechanical 
prophylaxis, the lack thereof points to an institutional failure that is 
likely to be present at many other hospitals in similar resource-limited 
environments. Ten patients received chemoprophylaxis despite having 
a documented contraindication, which may point to the inexperience 
of prescribers to consider bleeding risk or to desperate clinicians 
who have to make judgement calls on prophylaxis for high VTE-risk 
patients outside of guideline recommendations, thus exposing their 
patients to potential harm. The current shortage of unfractionated 
heparin in SA, with it becoming a section 21 drug, has often affected 
access to the only appropriate pharmacological thromboprophylaxis 
available at many state hospitals. This highlights another example 
of a system failure that may influence prescriber compliance with 
appropriate therapy in this setting.
SA is a resource-limited environment, where many hospitals 
continue to rely heavily on inexperienced junior doctors to manage 
patients, especially after-hours admissions and ongoing routine 
ward care. Numerous interventions have been proposed to improve 
VTE prophylaxis prescription, such as electronic alert systems, an 
opt-out thromboprophylaxis policy, performance evaluation and 
feedback, as well as practitioner education.[13-17] Although electronic 
prescription alerts and performance reviews are not be feasible 
in our setting, the inclusion of a risk assessment sheet on the 
inpatient prescription charts and providing continuous practitioner 
education are interventions that should be considered for improving 
VTE prophylaxis prescription. With such a high percentage of 
patients at risk, an opt-out policy of thromboprophylaxis prescription 
should also be considered.[18] Increased availability of mechanical 
prophylaxis for patients with contraindications to chemoprophylaxis 
is also essential, as a lack thereof significantly hampers the clinician’s 
ability to safely prevent VTE in patients with bleeding risks. 
Study limitations
A limitation of this study was that data were collected at a single 
point in time, with patients already admitted to the surgical ward. As 
Table 3. Risk stratification and prophylaxis prescription for 
at-risk surgical admissions
Caprini VTE risk score Patients, n Correct treatment, n (%)
Moderate (2) 36 4 (12)
High (3 - 4) 58 16 (28)
Highest (≥5) 43 15 (35)
Total 137 35 (26)
VTE = venous thromboembolism.
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there is evidence that a 24-hour delay in initiating VTE prophylaxis is 
linked to increased mortality, it would have been interesting to know 
how many patients started receiving the correct therapy according 
to their risk category, but also started at the right time.[19] This is 
especially relevant in the SA state sector, where patients may be left in 
busy admission units before being transferred to a ward. 
Another limitation of this single-point-in-time study was that the 
total duration of thromboprophylaxis was not reviewed, which is a 
further important factor to evaluate if correct thromboprophylaxis 
had been given during and after a patient’s hospital stay.
Conclusion
Despite a high proportion of patients at risk for VTE, the rate of 
adequate thromboprophylaxis prescription for surgical inpatients at 
Frere Hospital is very low in both emergency and elective groups. The 
lack of mechanical prophylaxis and heavy reliance on junior doctors 
for medication prescription may be factors contributing to the low 
compliance rate. More research is needed to assess the risk for  and 
impact of this common cause of morbidity and mortality in similar 
populations. Moreover, interventions to improve the rate of adequate 
prophylaxis prescription need to be evaluated for feasibility and effect 
in SA public sector hospitals. 
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